Summaries for patients. Reversibility of liver scarring in patients who are cured of thalassemia.
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002648:Child; D003131:Combined Modality Therapy; D003676:Deferoxamine / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000378:metabolism; D007502:Iron Chelating Agents / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000209:etiology* / Q000378:metabolism / Q000628:therapy*; D018962:Phlebotomy; D012074:Remission Induction; D012189:Retrospective Studies; D013789:Thalassemia / Q000150:complications* / Q000628:therapy*
D000998:Antiviral Agents; D007502:Iron Chelating Agents; D007501:Iron; D003676:Deferoxamine